GL1X · GenesisL1 explorer

UniProt P80601

2-iminobutanoate/2-iminopropanoate deaminase (P80601)

2-iminobutanoate/2-iminopropanoate deaminase (UniProt P80601), EC 3.1.-.-, 3.5.99.10: 10 experimental structures and 1 predicted model on GenesisL1, 3 ligands bound, 51 pockets. Binding sites, druggability and experiment against…

UniProt
P80601
Protein
2-iminobutanoate/2-iminopropanoate deaminase
EC
3.1.-.-, 3.5.99.10
Experimental structures
10
Predicted models
1
Ligands
3
Pockets
51 · 6 records with a druggable one

Structures

11 records of P80601 in the MolNFT archive: 10 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1NQ3Crystal structure of the mammalian tumor associated antigen UK114x-ray diffractionA, B, C, D, E, F—11 (best 0.81)
1NQ3Crystal structure of the mammalian tumor associated antigen UK114x-ray diffractionA, B, C, D, E, F—11 (best 0.81)
8Q3HCapra hircus reactive intermediate deaminase A mutant - A108Dx-ray diffractionA, B—2 (best 0.43)
8QOKCapra hircus reactive intermediate deaminase A mutant - E124Ax-ray diffractionA, B—3 (best 0.55)
8QOMCapra hircus reactive intermediate deaminase A mutant - R107Wx-ray diffractionA, B—1 (best 0.37)
8QOPCapra hircus reactive intermediate deaminase A - K78Ax-ray diffractionA, BNA—
8QOQCapra hircus reactive intermediate deaminase A mutant - R107Ax-ray diffractionA, B—3 (best 0.67)
8QOSCapra hircus reactive intermediate deaminase A - V25Wx-ray diffractionA, B, C, D, E, FK15 (best 0.83)
8QOUReactive intermediate deaminase A mutant - R107Kx-ray diffractionA, BNI4 (best 0.56)
8QOVCapra hircus reactive intermediate deaminase A mutant - I126Yx-ray diffractionA, BNI1 (best 0.36)
P80601AlphaFold monomer V2.0 prediction for 2-IMINOBUTANOATE/2-iminopropanoate deaminase (P80601)predictedA——

Ligands

  • NI · Nickel (II) ion · in 2 records
  • K · Potassium ion · in 1 record
  • NA · Sodium ion · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.